awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q57217007-229E0025-A774-40DF-A39E-5A134F9347D9
Q57217007-229E0025-A774-40DF-A39E-5A134F9347D9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57217007-229E0025-A774-40DF-A39E-5A134F9347D9
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P2860
Q57217007-229E0025-A774-40DF-A39E-5A134F9347D9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57217007-229E0025-A774-40DF-A39E-5A134F9347D9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
eec75306fefcb0b09b9a5e248559d92434e3f051
P2860
A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172).